SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2veo'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A7Y_B_DVAB2_0
(ACTINOMYCIN D)
2veo LIPASE A
(Moesziomyces
antarcticus)
3 / 3 THR A  23
PRO A  25
THR A  24
None
0.88A 1a7yB-2veoA:
undetectable
1a7yB-2veoA:
4.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 6 HIS A 366
ALA A 187
GLY A 182
TYR A 183
None
1.14A 1c8lA-2veoA:
undetectable
1c8lA-2veoA:
18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DHF_A_FOLA187_0
(DIHYDROFOLATE
REDUCTASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ILE A 150
ALA A 148
ILE A 301
PRO A 300
LEU A 305
PG4  A1443 ( 4.1A)
None
None
None
None
1.12A 1dhfA-2veoA:
undetectable
1dhfA-2veoA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DLS_A_MTXA188_1
(DIHYDROFOLATE
REDUCTASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ILE A 150
ALA A 148
ILE A 301
PRO A 300
LEU A 305
PG4  A1443 ( 4.1A)
None
None
None
None
1.11A 1dlsA-2veoA:
undetectable
1dlsA-2veoA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KYV_A_RBFA501_1
(6,7-DIMETHYL-8-RIBIT
YLLUMAZINE SYNTHASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 GLY A 240
SER A 239
LEU A 264
ILE A 252
ILE A 304
None
1.25A 1kyvA-2veoA:
3.5
1kyvE-2veoA:
undetectable
1kyvA-2veoA:
15.29
1kyvE-2veoA:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KYV_C_RBFC503_1
(6,7-DIMETHYL-8-RIBIT
YLLUMAZINE SYNTHASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ILE A 304
GLY A 240
SER A 239
LEU A 264
ILE A 252
None
1.25A 1kyvB-2veoA:
3.5
1kyvC-2veoA:
2.9
1kyvB-2veoA:
15.29
1kyvC-2veoA:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KYV_D_RBFD504_1
(6,7-DIMETHYL-8-RIBIT
YLLUMAZINE SYNTHASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ILE A 304
GLY A 240
SER A 239
LEU A 264
ILE A 252
None
1.24A 1kyvC-2veoA:
2.9
1kyvD-2veoA:
3.3
1kyvC-2veoA:
15.29
1kyvD-2veoA:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KYV_E_RBFE505_1
(6,7-DIMETHYL-8-RIBIT
YLLUMAZINE SYNTHASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ILE A 304
GLY A 240
SER A 239
LEU A 264
ILE A 252
None
1.25A 1kyvD-2veoA:
3.3
1kyvE-2veoA:
undetectable
1kyvD-2veoA:
15.29
1kyvE-2veoA:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A1M_A_CAMA1422_0
(CYTOCHROME P450-CAM)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 7 TYR A 107
THR A 123
GLY A 186
THR A 190
None
0.96A 2a1mA-2veoA:
undetectable
2a1mA-2veoA:
23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EGV_A_SAMA1300_0
(UPF0088 PROTEIN
AQ_165)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 LEU A 166
ASN A 168
GLY A 162
GLY A  34
LEU A 172
None
0.94A 2egvA-2veoA:
undetectable
2egvA-2veoA:
17.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EGV_B_SAMB1400_0
(UPF0088 PROTEIN
AQ_165)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 LEU A 166
ASN A 168
GLY A 162
GLY A  34
LEU A 172
None
0.98A 2egvB-2veoA:
undetectable
2egvB-2veoA:
17.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F9W_A_PAUA6001_0
(PANTOTHENATE KINASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 11 TYR A 183
GLY A 185
ASP A  95
ILE A 336
THR A 221
None
PG4  A1443 ( 4.3A)
PG4  A1443 (-3.1A)
None
PG4  A1443 (-4.1A)
1.14A 2f9wA-2veoA:
undetectable
2f9wB-2veoA:
undetectable
2f9wA-2veoA:
21.68
2f9wB-2veoA:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NPN_A_SAMA4633_0
(PUTATIVE COBALAMIN
SYNTHESIS RELATED
PROTEIN)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 9 THR A 123
TYR A 105
THR A 118
ALA A 119
LEU A 108
None
1.17A 2npnA-2veoA:
2.1
2npnA-2veoA:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3B_A_FOLA401_0
(DIHYDROFOLATE
REDUCTASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ILE A 150
ALA A 148
ILE A 301
PRO A 300
LEU A 305
PG4  A1443 ( 4.1A)
None
None
None
None
1.11A 2w3bA-2veoA:
undetectable
2w3bA-2veoA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3B_B_FOLB401_0
(DIHYDROFOLATE
REDUCTASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ILE A 150
ALA A 148
ILE A 301
PRO A 300
LEU A 305
PG4  A1443 ( 4.1A)
None
None
None
None
1.08A 2w3bB-2veoA:
undetectable
2w3bB-2veoA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3M_A_FOLA1188_0
(DIHYDROFOLATE
REDUCTASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ILE A 150
ALA A 148
ILE A 301
PRO A 300
LEU A 305
PG4  A1443 ( 4.1A)
None
None
None
None
1.05A 2w3mA-2veoA:
undetectable
2w3mA-2veoA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7K_A_SALA1303_1
(LYSR-TYPE REGULATORY
PROTEIN)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 7 SER A 377
PHE A  88
ILE A 381
TRP A 129
None
0.76A 2y7kA-2veoA:
undetectable
2y7kA-2veoA:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LD6_B_KKKB602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 PHE A 327
PHE A 435
GLY A 432
ALA A 430
THR A 118
None
1.37A 3ld6B-2veoA:
undetectable
3ld6B-2veoA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S54_B_017B201_1
(PROTEASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 LEU A 160
VAL A  92
GLY A 182
ILE A 163
ILE A 159
None
0.89A 3s54A-2veoA:
undetectable
3s54A-2veoA:
13.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRK_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 5 PHE A 431
GLY A 186
ILE A 336
VAL A 337
None
0.79A 3wrkA-2veoA:
undetectable
3wrkA-2veoA:
21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 PHE A  88
ILE A 126
ILE A 381
ALA A 187
GLY A 185
None
None
None
None
PG4  A1443 ( 4.3A)
1.15A 4enhA-2veoA:
undetectable
4enhA-2veoA:
24.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F93_B_SANB3004_1
(U5 SMALL NUCLEAR
RIBONUCLEOPROTEIN
200 KDA HELICASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 8 GLU A 253
ASN A 257
GLN A 261
GLY A 260
None
0.87A 4f93B-2veoA:
undetectable
4f93B-2veoA:
13.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FU9_A_ACTA311_0
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR)
2veo LIPASE A
(Moesziomyces
antarcticus)
3 / 3 GLN A  58
THR A  24
THR A  23
None
0.82A 4fu9A-2veoA:
undetectable
4fu9A-2veoA:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FUF_A_ACTA310_0
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR)
2veo LIPASE A
(Moesziomyces
antarcticus)
3 / 3 GLN A  58
THR A  24
THR A  23
None
0.82A 4fufA-2veoA:
undetectable
4fufA-2veoA:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G77_A_TLFA711_0
(LACTOTRANSFERRIN)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 7 ILE A 381
ALA A 179
VAL A 178
TYR A 135
None
0.79A 4g77A-2veoA:
undetectable
4g77A-2veoA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KFJ_B_FOLB202_0
(DIHYDROFOLATE
REDUCTASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ILE A 150
ALA A 148
ILE A 301
PRO A 300
LEU A 305
PG4  A1443 ( 4.1A)
None
None
None
None
1.07A 4kfjB-2veoA:
undetectable
4kfjB-2veoA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M48_A_21BA704_1
(TRANSPORTER)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 8 PHE A 380
SER A 210
GLY A 208
ALA A 354
None
0.91A 4m48A-2veoA:
undetectable
4m48A-2veoA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O1E_A_C2FA3000_1
(DIHYDROPTEROATE
SYNTHASE DHPS)
2veo LIPASE A
(Moesziomyces
antarcticus)
3 / 3 LYS A 382
ASN A 357
ASP A 386
None
0.85A 4o1eA-2veoA:
undetectable
4o1eA-2veoA:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PCU_B_SAMB603_0
(CYSTATHIONINE
BETA-SYNTHASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 9 LEU A  57
GLN A  56
VAL A  42
THR A  44
ILE A  46
None
1.48A 4pcuA-2veoA:
1.0
4pcuB-2veoA:
1.3
4pcuA-2veoA:
22.81
4pcuB-2veoA:
22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PO0_A_NPSA602_1
(SERUM ALBUMIN)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 8 ALA A 218
GLY A 237
LEU A 241
GLU A 155
PG4  A1443 (-4.4A)
PG4  A1443 (-3.6A)
PG4  A1443 ( 4.9A)
None
0.83A 4po0A-2veoA:
undetectable
4po0A-2veoA:
22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QB9_E_PARE500_1
(ENHANCED
INTRACELLULAR
SURVIVAL PROTEIN)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 PHE A 233
LEU A 367
GLU A 181
ASP A 122
GLY A 213
PG4  A1443 (-4.7A)
None
None
None
None
1.35A 4qb9E-2veoA:
1.1
4qb9E-2veoA:
23.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R87_I_SPMI202_1
(SPERMIDINE
N1-ACETYLTRANSFERASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 7 MET A 157
GLU A 154
GLU A 155
GLU A 308
None
1.19A 4r87I-2veoA:
0.6
4r87I-2veoA:
18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECM_A_LEUA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 5 THR A 190
ALA A 187
TYR A  90
HIS A 211
None
1.25A 5ecmA-2veoA:
undetectable
5ecmA-2veoA:
23.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_A_TRPA101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 9 THR A 214
GLY A 182
ALA A 209
HIS A 188
THR A 190
None
1.45A 5eeuA-2veoA:
undetectable
5eeuB-2veoA:
undetectable
5eeuA-2veoA:
9.68
5eeuB-2veoA:
9.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_A_P06A801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 7 ILE A 404
GLY A 403
PHE A 358
PHE A 380
None
1.03A 5hieA-2veoA:
undetectable
5hieA-2veoA:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IK1_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 7 PHE A 431
GLY A 186
ILE A 336
VAL A 337
None
0.64A 5ik1A-2veoA:
undetectable
5ik1A-2veoA:
22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)
2veo LIPASE A
(Moesziomyces
antarcticus)
5 / 12 ASP A  18
ALA A  11
THR A 118
ARG A 270
GLY A 271
None
1.20A 5m5cB-2veoA:
2.4
5m5cB-2veoA:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UXD_A_ZITA501_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E MPHH)
2veo LIPASE A
(Moesziomyces
antarcticus)
4 / 7 TYR A  22
PHE A 145
ALA A 158
GLY A 162
None
0.96A 5uxdA-2veoA:
undetectable
5uxdA-2veoA:
23.30